Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 6
Results: 14
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/ neu-positive tumour cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 915, doi. 10.1007/s00262-008-0607-1
- By:
- Publication type:
- Article
Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 901, doi. 10.1007/s00262-008-0606-2
- By:
- Publication type:
- Article
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 967, doi. 10.1007/s00262-008-0612-4
- By:
- Publication type:
- Article
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 941, doi. 10.1007/s00262-008-0609-z
- By:
- Publication type:
- Article
Apoptosis of CD4<sup>+</sup>CD25<sup>high</sup> T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 867, doi. 10.1007/s00262-008-0602-6
- By:
- Publication type:
- Article
Targets for active immunotherapy against pediatric solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 831, doi. 10.1007/s00262-008-0619-x
- By:
- Publication type:
- Article
Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 843, doi. 10.1007/s00262-008-0600-8
- By:
- Publication type:
- Article
The immunosuppressive tumor microenvironment in hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 877, doi. 10.1007/s00262-008-0603-5
- By:
- Publication type:
- Article
Focal adhesion kinase as an immunotherapeutic target.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 931, doi. 10.1007/s00262-008-0608-0
- By:
- Publication type:
- Article
Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 887, doi. 10.1007/s00262-008-0605-3
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 955, doi. 10.1007/s00262-008-0611-5
- By:
- Publication type:
- Article
Lentiviral vectors encoding human MUC1-specific, MHC-unrestricted single-chain TCR and a fusion suicide gene: potential for universal and safe cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 977, doi. 10.1007/s00262-008-0624-0
- By:
- Publication type:
- Article
Low representation of Fc receptor-like 1–5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 989, doi. 10.1007/s00262-008-0589-z
- By:
- Publication type:
- Article
Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 855, doi. 10.1007/s00262-008-0601-7
- By:
- Publication type:
- Article